-- Diluted EPS of $1.27; Adjusted Diluted EPS of $1.30 --
Total revenues up 11% from the third quarter of 2021 driven by organic Medicaid and Medicare growth.
Health benefits ratio (HBR) of 88.3%, driven by strong Medicare results and inline performance from Medicaid and Commercial.
Value Creation Plan gaining momentum:
4th guidance raise in 2022 totaling a cumulative $0.30, or 5.5%, increase to the mid-point of the 2022 full-year adjusted diluted EPS guidance to a range of $5.65 to $5.75.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.